The transaction, initially announced in August, combines Healthcare IT Leaders' consulting depth with Kyndryl’s global enterprise scale. By absorbing the firm, Kyndryl intends to provide hospitals and health systems with a unified provider capable of managing complex, highly regulated technology environments ranging from clinical applications to workforce management systems.

Financially, the acquisition accounted for roughly 1% of Kyndryl's fiscal 2026 revenue. While the company maintains its current fiscal 2027 outlook, it has opted to temporarily pause its share repurchase program to preserve capital liquidity. This decision aligns with the firm's broader strategy of prioritizing investments in growth initiatives while maintaining its investment-grade financial standing.